Health Catalyst, Inc. announced it has repurchased shares of its common stock totaling approximately $5 million. These shares were acquired between March 3, 2025, and March 10, 2025, as part of the company's existing share repurchase program.
The repurchases resulted in the retirement of approximately 1.1 million shares of common stock. This action falls under the $40 million share repurchase program that was initially approved by Health Catalyst's board of directors on August 2, 2022.
CEO Dan Burton stated that the repurchase underscores the company's confidence in its future business and its anticipated continued achievement of operating leverage and reacceleration of revenue growth. This move demonstrates a commitment to creating long-term, sustainable value for shareholders.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.